#United States #Los Angeles #ALS Research #ALS Network #ACT for ALS

ALS Network Calls for Congressional Support on Critical ALS Legislation

The ALS Network, a key organization in the fight against amyotrophic lateral sclerosis (ALS), has recently announced its backing of the reintroduction of the Accelerating Access to Critical Therapies (ACT) for ALS Act (H.R.8205). This bipartisan legislation, led by Representatives Mike Quigley and Ken Calvert, aims to make significant strides in ALS research and therapy accessibility, directly benefitting individuals battling this challenging disease.

The organization has been actively collaborating with champions and advocates from the ALS community to ensure the reauthorization of this vital act through to 2031. The ACT for ALS Act notably established a framework focusing on patient-centered strategies to advance research and expand access to investigational therapies, particularly for those unable to enroll in standard clinical trials. Such initiatives are increasingly crucial in the fight against a condition characterized by its rapid progression and limited treatment options.

"Every day, we hear from individuals and families navigating the realities of ALS, where time is incredibly limited and options are few," stated Sheri Strahl, president and CEO of the ALS Network. "Families do not have the luxury of waiting."

In essence, the ACT for ALS Act lays the groundwork for a more efficient and coordinated approach to research for ALS while facilitating access to therapies that may provide hope for many living with the disease. The ALS Network emphasizes that sustaining the momentum can provide patients with more opportunities for progressive treatments while research for breakthroughs continues.

The call for urgent congressional action is echoed by the organization’s concerns regarding the potential consequences of failing to reauthorize the act. Without continued support, programs aimed at expanding access to crucial investigational therapies could start to fade, dismantling the existing efforts to advance ALS research infrastructure. Such disruptions would significantly hinder progress not only for patients and their families but also for researchers striving to find effective treatments.

As advocates for ALS patients, the ALS Network is imploring members of Congress to act decisively and swiftly to reauthorize this critical legislation. This appeal comes in light of the pressing need to protect the interests of those living with this debilitating illness.

The ALS Network has long been committed to driving forward the discovery of prevention strategies, treatments, and cures for ALS. Additionally, they focus on providing quality care and fostering connections within the ALS community. Previously known as ALS Golden West, the network serves individuals and families impacted by ALS across California and Hawaii, among other regions.

Individuals interested in learning more about the ALS Network’s initiatives or how to get involved can visit their official website at alsnetwork.org or reach out directly via email. The organization is also active on social media platforms, where they share updates and resources.

As advocates rally together, the hope is for a reauthorization of the ACT for ALS Act to pave the way for significant advancements in ALS treatment and research. Time is of the essence as the ALS community collectively strives for progress in the continuing battle against this challenging disease.